ClinicalTrials.Veeva

Menu

A Clinical Study to Evaluate the Pharmacokinetic Profile of SB-649868 in Elderly and Female Population

GlaxoSmithKline (GSK) logo

GlaxoSmithKline (GSK)

Status and phase

Withdrawn
Phase 1

Conditions

Insomnia

Treatments

Drug: SB-649868

Study type

Interventional

Funder types

Industry

Identifiers

NCT00534872
OXS109143

Details and patient eligibility

About

The purpose of this study is to determine the blood levels and the tolerability of SB-649868 in Elderly and Female population

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy adult and elderly female and male
  • Female must be of non-childbearing potential
  • Body weight =50 kg

Exclusion criteria

  • Abuse of alcohol or drugs
  • Positive for Hepatitis B surface antigen, Hepatitis C antibody or HIV
  • Use of prescription or non-prescription drugs within 7 days prior to the first dose of study medication
  • Smoking history of = 10 cigarettes a day in the last three months
  • History of cardiovascular,psychiatric,autoimmune, respiratory or relevant gastrointestinal diseases
  • Participation in clinical trial during the previous 6 months

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

0 participants in 1 patient group

SB649868
Experimental group
Description:
10 mg
Treatment:
Drug: SB-649868

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems